Pharma Excipients

News on Pharma Excipients

Manipulation of solid dosage forms for oral administration to paediatric patients for drug-resistant tuberculosis in South Africa: an observation study

Abstract Background Children represent a particularly vulnerable demographic in the context of drug-resistant (DR) tuberculosis (TB) due to their increased likelihood of close contact with adults diagnosed with the disease. Approximately 25 000–30 000 children develop DR-TB annually. While treatment success rates for DR-TB in children surpass…

Meggle Introduces Triple Compound CombiLac

13. May 2015 Meggle Introduces Triple Compound CombiLac Meggle has launched the new high-functionality excipient (HFE) CombiLac, a lactose-based, co-processed excipient, specifically designed to ease oral solid…
Read More...